Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
173
NCT01969799
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 31, 2013
Completion: Apr 30, 2016
NCT02218359
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative and / or Gram-positive Bacterial Colonization
Start: Oct 31, 2014
Completion: Jan 31, 2016
NCT02709265
Open-Label Phase 1 Study of Aerosolized Amikacin and Fosfomycin in Healthy Volunteers
Phase: Phase 1
Start: Apr 30, 2016
Completion: Jul 31, 2016